Skip to content

Cognitive Intervention to Improve Memory in Heart Failure Patients

Cognitive Intervention to Improve Memory in Heart Failure Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03035565
Acronym
Memoir-HF
Enrollment
276
Registered
2017-01-30
Start date
2017-02-22
Completion date
2021-09-30
Last updated
2023-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure NYHA Class I, Heart Failure NYHA Class II, Heart Failure NYHA Class III

Keywords

Heart Failure, Cognition in Heart Failure

Brief summary

Cognitive Intervention to Improve Memory in Heart Failure patients

Detailed description

A three arm randomized controlled trial of 276 heart failure patients.

Interventions

BEHAVIORALComputerized Cognitive Training with Brain HQ

Computerized Cognitive Training Brain HQ activities initiated and continued 1 hour/day, 5 days/week for 8 weeks

Computerized Crossword Puzzles activities initiated and continued 1 hour/day, 5 days/week for 8 weeks

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 21 years of age * Understands English * Has access to a telephone * Hears normal conversation * For patients with hearing aids, able to wear and hear through headsets * Diagnosis of chronic heart failure, stage C, NYHA I, II or III * Receiving guideline derived medical therapy * Heart failure validated by echocardiography or other method in past 2 years * Able to read a computer screen with or without glasses or lenses

Exclusion criteria

* History of drug or alcohol abuse or major psychiatric diagnosis present before the heart failure diagnosis * Alzheimer or other dementia diagnosis or central nervous system degenerative disorder * Terminal cancer * Patients with baseline Montreal Cognitive Assessment (MoCA) score of less than 19 Supplement Eligibility: First 144 patients randomized in the parent trial.

Design outcomes

Primary

MeasureTime frameDescription
Change in serum brain derived neurotrophic factor ( BDNF) LevelAt 8 monthsCo-Primary Outcome
Change in delayed recall memory as measured by Hopkins Verbal Learning TestAt 8 monthsChange in delayed recall memory as measured by Hopkins Verbal Learning Test

Secondary

MeasureTime frameDescription
Change in instrumental activities of daily living as measured by Everyday Problems TestAt 8 monthsChange in instrumental activities of daily living as measured by Everyday Problems Test
Cost-effectiveness of the Brain HQ training intervention as measured by calculating the Incremental cost effectiveness ratios (ICERs) using medical services costsAt 8 monthsCost-effectiveness of the Brain HQ training intervention as measured by calculating the Incremental cost effectiveness ratios (ICERs) using medical services costs
Change in health-related quality of life as measured by Minnesota Living with Heart Failure QuestionnaireAt 8 monthsChange in health-related quality of life as measured by Minnesota Living with Heart Failure Questionnaire
Change in working memory as measured by CogState One Back Accuracy TaskAt 8 monthsChange in working memory as measured by CogState One Back Accuracy Task

Other

MeasureTime frameDescription
Cognitive Intervention to Improve Memory in Heart Failure Patients - SupplementAcross 36 monthsRisk of amnestic mild cognitive impairment, Alzheimer disease and related dementias, and memory decline across 36 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026